Denis, Kevin <br/><br/>
Targeting Type IV pili as an antivirulence strategy against invasive meningococcal disease.  [electronic resource] 

 -  Nature microbiology  06 2019 
 - 972-984 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2058-5276 
<br/><br/><label>Standard No.: </label>10.1038/s41564-019-0395-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Bacterial Agents--pharmacology<br/>Blood Vessels--injuries<br/>Drug Combinations<br/>Electron Transport Complex I<br/>Female<br/>Fimbriae, Bacterial--drug effects<br/>Gene Expression Profiling<br/>Gene Expression Regulation, Bacterial--drug effects<br/>Gram-Negative Bacteria<br/>Humans<br/>Meningococcal Infections--prevention & control<br/>Mice<br/>Neisseria meningitidis--drug effects<br/>Phenothiazines--pharmacology<br/>Skin--pathology<br/>Skin Transplantation<br/>Sodium-Potassium-Exchanging ATPase<br/>Trifluoperazine--pharmacology<br/>Virulence Factors